Related Experiment Video
Updated: Jul 17, 2026
11:20
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy
J K Luttrull1, D C Musch, C A Spink
1jkluttrull@aol.com
Eye (London, England)
|February 13, 2007
Summary
Subthreshold diode micropulse panretinal photocoagulation (SDM PRP) effectively treated diabetic retinopathy with minimal complications. This method preserved visual acuity and reduced risks of vitreous hemorrhage and vitrectomy.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Diabetic Retinopathy Treatment
Background:
- Diabetic retinopathy is a leading cause of vision loss.
- Panretinal photocoagulation (PRP) is a standard treatment for proliferative diabetic retinopathy.
- Traditional PRP can cause complications and visual field defects.
Purpose of the Study:
- To evaluate the visual acuity and clinical outcomes of subthreshold diode micropulse panretinal photocoagulation (SDM PRP).
- To assess the safety and efficacy of SDM PRP in managing diabetic retinopathy.
Main Methods:
- Retrospective chart review of 99 eyes from 63 patients with diabetic retinopathy treated with SDM PRP.
- SDM PRP protocol aimed to avoid detectable laser lesions.
- Treatment failure defined as vitreous haemorrhage or vitrectomy.
Main Results:
- Visual acuity remained stable post-treatment.
- 12-month probabilities of treatment failure were 12.5% for vitreous haemorrhage and 14.6% for vitrectomy.
- No treatment complications or detectable laser lesions were observed.
Conclusions:
- SDM PRP minimizes retinal damage and complications in treating diabetic retinopathy.
- Visual loss was prevented with low rates of vitreous haemorrhage and vitrectomy.
- Further research on SDM PRP safety, efficacy, and parameters is recommended.
